Kd, in particular, plays a pivotal role in the internalization of ADCs into cancer cells; a lower Kd indicates a higher binding affinity between the antibody and the neonatal Fc receptor (FcRn) on the tumor cell surface, which can paradoxically lead to reduced efficacy. This evidence concerns the gene FCGRT and neoplasm.